Compounds > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and 2-(6-chloro-2-(4-(3-fluoropropoxy)phenyl)imidazo(1,2-a)pyridin-3-yl)-n,n-diethylacetamide

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with 2-(6-chloro-2-(4-(3-fluoropropoxy)phenyl)imidazo(1,2-a)pyridin-3-yl)-n,n-diethylacetamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berghofer, PJ; Bourdier, T; Callaghan, PD; Gregoire, MC; Greguric, I; Howell, NR; Jackson, T; Katsifis, A; Loc'h, C; Mattner, F; Pastuovic, Z; Pham, TQ; Rahardjo, GL; Siegele, R; Wimberley, CA; Wyatt, N; Zahra, D1

Other Studies

1 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and 2-(6-chloro-2-(4-(3-fluoropropoxy)phenyl)imidazo(1,2-a)pyridin-3-yl)-n,n-diethylacetamide

ArticleYear
Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [(18)F]PBR102 and [ (18)F]PBR111 in a model of excitotoxin-induced neuroinflammation.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain; Carrier Proteins; Imidazoles; Inflammation; Male; Positron-Emission Tomography; Protein Binding; Pyridines; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, GABA-A; Signal-To-Noise Ratio

2015